India Inflation Target Retained at 4 Percent Through 2031
India's inflation target retained at 4 percent through 2031. What this signals about RBI policy and what it means for your loans, EMIs, and savings.
Markets, companies, startups, and economic policy affecting India.
India's inflation target retained at 4 percent through 2031. What this signals about RBI policy and what it means for your loans, EMIs, and savings.
Cabinet approves UDAN 2.0: ₹28,840 crore for 100 airports and 200 helipads over 10 years. Only 45.6% of original UDAN routes survived. What changed.
Gross FDI into India is up 15% but net FDI has been negative for 6 months. Foreign investors are pulling out faster than they're coming in.
RBI forex reserves in March 2026 fell $20 billion defending the rupee. Import cover is at a three-year low. How long can the central bank keep this up?
India's stock market crash March 2026: Sensex fell 1,836 points, rupee hit 93.98. Hormuz chaos and FPI flight wiped ₹14L crore. Here's why.
India's 2026 fertilizer shortage deepens as Hormuz blockade cuts 44% of urea exports. China restricts supply. Yara slashes output. Kharif season starts in 10 weeks.
50+ generic Ozempic brands launch in India at ₹3,000/month after patent expiry. Down from ₹11,000 — but 250 million obese Indians are still priced out.
IDBI Bank privatisation restarts from scratch after bids fell short. Stock crashed 20% in two days. What it means for India's disinvestment plans.
India's Russian oil imports hit a 44-month low under US tariff pressure. Now Hormuz is closed and Moscow is offering 9.5M barrels via alternative routes.
Semaglutide generics launch March 21 at ₹3,000-5,000/month — 50-70% cheaper than Ozempic. 50+ brands incoming, but price isn't the real barrier.